<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04813848</url>
  </required_header>
  <id_info>
    <org_study_id>5877/2020</org_study_id>
    <nct_id>NCT04813848</nct_id>
  </id_info>
  <brief_title>Effectiveness of a Bonding and a Fluoride Varnish for Long-term Dentin Hypersensitivity Treatment.</brief_title>
  <official_title>Effectiveness of a Bonding and a Fluoride Varnish for Long-term Dentin Hypersensitivity Treatment: a Split-mouth Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives:&#xD;
&#xD;
      The aim of this in vivo randomized clinical trial with split-mouth design was to evaluate the&#xD;
      clinical efficacy of one in-office application of a fluoride containing varnish and in office&#xD;
      application of a bonding resin in adult patients presenting with dentin hypersensitivity.&#xD;
&#xD;
      Materials and Methods:&#xD;
&#xD;
      The study cohort consisted of 38 Caucasian outpatients, giving a total of 180 teeth were&#xD;
      treated by fluoride varnish (FV) and 160 - by bonding agent (BA). Baseline pain in FV group&#xD;
      was slightly higher on both scales (SCHIFF and VAS). Outcome measurements were assessed one&#xD;
      or two weeks before product application (enrollment), at baseline at the application days&#xD;
      (end of the run-in period: T0a, T0b, T0c), and at 1 week and at 1-2-6 months after first&#xD;
      treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2020</start_date>
  <completion_date type="Actual">February 1, 2021</completion_date>
  <primary_completion_date type="Actual">September 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized, slit-mouth, double blind clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of Pain assessment with the Schiff Sensitivity Scale</measure>
    <time_frame>All study participants were asked to record the pain intensity score at the baseline, before the application of the desensitizing agents</time_frame>
    <description>A score of 0, 1, 2 or 3 was given by the participant. 0 = No subject response to stimulus, 1 = Subject response but will continue, 2 = Subject responds and moves or requests discontinuation, 3 = Painful response to stimulus, discontinuation requested.&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of Pain assessment with the Schiff Sensitivity Scale</measure>
    <time_frame>All study participants were asked to record the pain intensity score at seven days after the application of the desensitizing agents</time_frame>
    <description>A score of 0, 1, 2 or 3 was given by the participant. 0 = No subject response to stimulus, 1 = Subject response but will continue, 2 = Subject responds and moves or requests discontinuation, 3 = Painful response to stimulus, discontinuation requested.&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of Pain assessment with the Schiff Sensitivity Scale</measure>
    <time_frame>All study participants were asked to record the pain intensity score at one month after the application of the desensitizing agents</time_frame>
    <description>A score of 0, 1, 2 or 3 was given by the participant. 0 = No subject response to stimulus, 1 = Subject response but will continue, 2 = Subject responds and moves or requests discontinuation, 3 = Painful response to stimulus, discontinuation requested.&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of Pain assessment with the Schiff Sensitivity Scale</measure>
    <time_frame>All study participants were asked to record the pain intensity score at two months after the application of the desensitizing agents</time_frame>
    <description>A score of 0, 1, 2 or 3 was given by the participant. 0 = No subject response to stimulus, 1 = Subject response but will continue, 2 = Subject responds and moves or requests discontinuation, 3 = Painful response to stimulus, discontinuation requested.&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of Pain assessment with the Schiff Sensitivity Scale</measure>
    <time_frame>All study participants were asked to record the pain intensity score at six months after the application of the desensitizing agents</time_frame>
    <description>A score of 0, 1, 2 or 3 was given by the participant. 0 = No subject response to stimulus, 1 = Subject response but will continue, 2 = Subject responds and moves or requests discontinuation, 3 = Painful response to stimulus, discontinuation requested.&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of Pain assessment with the Visual Analogue Scale (VAS)</measure>
    <time_frame>All study participants were asked to record the pain intensity score at the baseline, before the application of the desensitizing agents</time_frame>
    <description>The level of pain was evaluated on a visual scale from 0 (&quot;no pain&quot;) to 10 (&quot;maximum pain&quot;).&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Pain assessment with the Visual Analogue Scale (VAS)</measure>
    <time_frame>All study participants were asked to record the pain intensity score at seven days after the application of the desensitizing agents</time_frame>
    <description>The level of pain was evaluated on a visual scale from 0 (&quot;no pain&quot;) to 10 (&quot;maximum pain&quot;).&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Pain assessment with the Visual Analogue Scale (VAS)</measure>
    <time_frame>All study participants were asked to record the pain intensity score at one month after the application of the desensitizing agents</time_frame>
    <description>The level of pain was evaluated on a visual scale from 0 (&quot;no pain&quot;) to 10 (&quot;maximum pain&quot;).&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Pain assessment with the Visual Analogue Scale (VAS)</measure>
    <time_frame>All study participants were asked to record the pain intensity score at two months after the application of the desensitizing agents</time_frame>
    <description>The level of pain was evaluated on a visual scale from 0 (&quot;no pain&quot;) to 10 (&quot;maximum pain&quot;).&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Pain assessment with the Visual Analogue Scale (VAS)</measure>
    <time_frame>All study participants were asked to record the pain intensity score at six months after the application of the desensitizing agents</time_frame>
    <description>The level of pain was evaluated on a visual scale from 0 (&quot;no pain&quot;) to 10 (&quot;maximum pain&quot;).&#xD;
The lower the score, the lower the hypersensitivity. Air-blast stimulus was used: the response to a jet of cold air was rated by the examiner.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>To Decrease Dentin Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Varnish fluoride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Varnish fluoride to be applied on the surface of exposed dentin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bonding agent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bonding agent to be applied on the surface of exposed dentin</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Application of varnish fluoride desensitizing agent on buccal surfaces of exposed dentin</intervention_name>
    <description>Varnish fluoride is a single dose transparent varnish with 5 % sodium fluoride (22.600 ppm fluoride) and 5 % calcium fluoride.&#xD;
The application was performed according to the manufacturer's instructions. The varnish was applied on a clean and dry surface, then after 10-20 seconds to allow the fluoride varnish to be absorbed, was then dried with air.</description>
    <arm_group_label>Varnish fluoride</arm_group_label>
    <other_name>Bifluorid, Voco GmbH</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Application of bonding agent desensitizing agent on buccal surfaces of exposed dentin</intervention_name>
    <description>Bonding agent is a single dose dual curing universal adhesive and its application was performed according to the manufacturer's instruction for cases with hypersensitive tooth necks. The bonding was applied without etching, on a clean and dry surface. After 10 s any excess material was removed and then light cured for 30 s.</description>
    <arm_group_label>Bonding agent</arm_group_label>
    <other_name>Futurabond U, Voco GmbH</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  absence of systemic pathologies (ASA class I);&#xD;
&#xD;
          -  not pregnant or lactating;&#xD;
&#xD;
          -  good oral hygiene;&#xD;
&#xD;
          -  with â‰¥1 sensitive tooth with exposed dentin on upper or lower dental arches;&#xD;
&#xD;
          -  contemporary presence of exposed dentin both on the left and right counterpart of&#xD;
             upper or lower arch.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  domestic or in-office professional fluoride application and bleaching 6 months before&#xD;
             beginning of treatment;&#xD;
&#xD;
          -  long-term use of anti-inflammatory, analgesic and psychotropic drugs;&#xD;
&#xD;
          -  eating disorders, systemic conditions that cause or predispose patients to develop&#xD;
             dentin hypersensitivity (for example, Gastroesophageal reflux disease);&#xD;
&#xD;
          -  periodontal surgery and within the previous three months before the study;&#xD;
&#xD;
          -  orthodontic treatment within the previous three months before the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Livia Ottolenghi, DDS,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sapienza University of Rome</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Oral and Maxillo-Facial Sciences, Sapienza University of Rome</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 21, 2021</study_first_submitted>
  <study_first_submitted_qc>March 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>March 21, 2021</last_update_submitted>
  <last_update_submitted_qc>March 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Livia Ottolenghi</investigator_full_name>
    <investigator_title>DDS, PhD, Full Professor, Deputy Dean of the Faculty of Medicine and Dentistry, Dean of the Dental School</investigator_title>
  </responsible_party>
  <keyword>dentin hypersensitivity</keyword>
  <keyword>bonding agent</keyword>
  <keyword>fluoride varnish</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dentin Sensitivity</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

